LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to ...
WASHINGTON, DC: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla in the Oval Office of the White House as he announces a deal with Pfizer to lower drug prices on September 30, ...
Ediitor's note: This article was updated at 7p ET with confirmation by the White House and additional details. President Trump Friday afternoon announced that AstraZeneca has made a deal with his ...
Hosted on MSN
Trump’s AstraZeneca Deal Echoes Pfizer Pact. Big Pharma’s Political Headaches Are Easing.
The press conference that President Donald Trump hosted in the Oval Office with the CEO of drugmaker AstraZeneca on Friday played like a rerun of the late September Oval Office press conference with ...
AstraZeneca has kept pace with drug rival Pfizer in striking a pricing deal with the Trump White House. AstraZeneca PLC announced a deal with President Donald Trump that's focused on lowering drug ...
NEW YORK, May 1 (Reuters) - Rumors about a massive healthcare deal were circulating in industry circles, months before Pfizer Inc disclosed its $100 billion pursuit of Britain's AstraZeneca Plc , ...
After months of coercion, President Donald Trump has found another pharma giant willing to play ball with his "most favored nation" (MFN) drug pricing program. AstraZeneca has reached an agreement to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results